Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial - Concepedia

Concepedia

Publication | Open Access

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

DOI Full Paper Access

1.2K

Citations

19

References

2015

Year

Bryan Williams, Thomas M. MacDonald, S. V. Morant, David R. Webb, Peter Sever, Gordon T. McInnes, Ian Ford, J. CRUICKSHANK, Mark J. Caulfield, Jackie Salsbury,

References

	Year	Citations

Page 1